Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics

MLA

Nan Jin, et al. “Identification of Potential Serum Biomarkers for Congenital Heart Disease Children with Pulmonary Arterial Hypertension by Metabonomics.” BMC Cardiovascular Disorders, vol. 23, no. 1, Mar. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12872-023-03171-5.

APA

Nan Jin, Mengjie Yu, Xiaoyue Du, Zhiguo Wu, Changlin Zhai, Haihua Pan, Jinping Gu, & Baogang Xie. (2023). Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics. BMC Cardiovascular Disorders, 23(1), 1–11. https://doi.org/10.1186/s12872-023-03171-5

Chicago

Nan Jin, Mengjie Yu, Xiaoyue Du, Zhiguo Wu, Changlin Zhai, Haihua Pan, Jinping Gu, and Baogang Xie. 2023. “Identification of Potential Serum Biomarkers for Congenital Heart Disease Children with Pulmonary Arterial Hypertension by Metabonomics.” BMC Cardiovascular Disorders 23 (1): 1–11. doi:10.1186/s12872-023-03171-5.